mdatl.com
 
vicodin online
 
News Events Profiles Clinical Management Directory
 
 
 
 

Archive for the ‘News’ Category

Kahn named medical director of radiation oncology at Winship at Emory Saint Joseph’s Hospital

Sunday, August 27th, 2017

Shannon Kahn, MD

Winship Cancer Institute (Winship) has named Shannon Kahn, MD, medical director of radiation oncology at Emory Saint Joseph’s Hospital. A board certified radiation oncologist, Kahn joined the Winship staff at Emory Saint Joseph’s five years ago and specializes in the treatment of patients with malignant and benign brain tumors, breast and lung cancers.

She is skilled at Gamma Knife radiosurgery, a minimally invasive radiation treatment for malignant and nonmalignant tumors, trigeminal neuralgia (facial pain syndrome), and other neurological disorders.

“Shannon is an extraordinary physician and has already established herself as a great leader at Winship at Emory Saint Joseph’s Hospital,” says Winship Executive Director Walter J. Curran, Jr., MD.

Prior to her career in medicine, Kahn earned her Bachelor of Science in Business Administration and a Master in Accountancy at the University of North Carolina at Chapel Hill and worked for Arthur Andersen as a certified public accountant and financial auditor. When her mother was diagnosed with breast cancer, Kahn decided to pursue a career in medicine. She earned her degree from the Emory University School of Medicine, completing her internship in internal medicine and residency in radiation oncology at Emory University.

Kahn has authored and co-authored several presentations at national research and healthcare meetings and many publications in national and international peer-reviewed journals. She has published on the use of radiotherapy for patients with Hodgkin’s and non-Hodgkin’s lymphoma, the effectiveness and side-effect profile of radiotherapy in the treatment of prostate cancer, and the use of alternative treatment modalities for long-term treatment sequelae among patients with head and neck cancer.

Kahn is a member of Winship’s Cancer Prevention and Control Research Program. Her society memberships include the American Medical Association, the American Society of Therapeutic Radiology and Oncology, and the American Society of Clinical Oncology.

Share

Paul Scheinberg, MD retires after 38-year career at Emory Saint Joseph’s Hospital

Tuesday, August 29th, 2017

Paul Scheinberg, MD, chief medical officer and chief quality officer for Emory Saint Joseph’s Hospital, has retired after a 38-year career in pulmonology.

Scheinberg built a practice and was a founding partner of Atlanta Pulmonary Group. Since 1979, he was actively engaged in the practice of pulmonology and critical care medicine at Saint Joseph’s Hospital. A self-described “clinician at heart,” Scheinberg dedicated his career to patient care, and also to mentoring many physicians. “The relationship with my patients has been so rewarding, and I have learned from all of them. I have always focused my attention on being the best physician I could be for them,” he says.

During his career at the hospital, Scheinberg received the Napier Burson Physician of Distinction award in 2013, Emory Saint Joseph’s highest honor for physician service. Scheinberg was awarded this honor based upon his adherence to the Mercy philosophy and contribution to the Mercy mission in Atlanta; his contribution to the quality of medicine practiced at Emory Saint Joseph’s; and leadership as a member of the medical staff.

In addition to serving as chief medical officer and chief quality officer at Emory Saint Joseph’s, Scheinberg’s leadership positions also included serving as chief of the medical staff, chair of the Department of Medicine and chief of the Pulmonary Section.

“We are grateful to Dr. Scheinberg for his tireless commitment to Emory Saint Joseph’s and patients in our community, and as a valued colleague, we will miss his contributions on our team,” says Heather Dexter, CEO of Emory Saint Joseph’s.

Throughout his career, Scheinberg dedicated significant time to research and served as principal investigator in numerous studies involving chronic lung disease, acute exacerbation of chronic bronchitis, pneumonia and bronchiectasis, as well as sleep disorders and smoking cessation.

Scheinberg’s first experience in the field of medicine occurred at the age of five, when he followed his physician father on rounds at Maimonides Medical Center in Brooklyn, New York. “There was never a question in my mind about becoming a doctor,” he says about following his father’s model and dedication to medicine.

Scheinberg received his medical degree from the State University of New York Downstate Medical School, and completed his internal medicine residency at Grady Memorial Hospital. During his residency, he served as a flight surgeon in the U.S. Navy, where he studied and developed an interest in pulmonary physiology. He completed his internship and residency in internal medicine at Emory University, followed by a fellowship in pulmonary diseases at Emory.

In addition to his medical career, Scheinberg has been actively involved for many years with the Jewish National Fund, establishing medical facilities in the southern area of Israel near Negev and the Jordanian border. He also established relationships with a delegation of Israeli mayors and community leaders from the Western Galilee Cluster. During a visit to Emory Saint Joseph’s last fall, Scheinberg introduced the group to various areas of medical technology and patient care.

Share

Northside Hospital offers new NETSPOT diagnostic imaging tool for the detection, staging and restaging of rare neuroendocrine tumors

Monday, August 28th, 2017

A new tool available at Northside Hospital aims to locate, stage and restage rare neuroendocrine tumors (NETs) in patients, helping doctors find disease that they were unable to see before.

More than 12,000 people in the United States are diagnosed with NETs each year, according to the Neuroendocrine Tumor Research Foundation. NETs develop in the hormone-producing cells of the body’s neuroendocrine system.

Most NETs are not harmful. They often form in the intestine, pancreas or lungs, but sometimes trigger a rare form of cancer that can be difficult to diagnose with current imaging techniques.

The Northside Hospital Cancer Institute treats more than 300 newly diagnosed cases of NETs year. The hospital is one of only a handful in the Southeast to offer NETSPOT®, a product recently approved by the U.S. Food and Drug Administration for the preparation of Gallium-68 (Ga-68) dotatate for PET/CT (positron emission tomography – computed tomography) imaging.

“NETSPOT provides a more sensitive and specific imaging tool to determine location of disease, for staging and restaging of patients with well-differentiated and moderately-differentiated NETs,” said Dr. William C. Lavely, nuclear medicine specialist at Northside Radiology Associates.

Ga-68 dotatate is a radioactive diagnostic agent that is specifically designed to detect somatostatin receptors, including those in NETs. When injected into the patient, the agent binds to the receptors.

“Somatostatin is a hormone that regulates the endocrine system and is expressed by neuroendocrine cells,” said Dr. Lavely. “This provides a unique target for neuroendocrine tumor imaging.”

Combined with PET/CT imaging, which offers higher resolution, three-dimensional and more rapid imaging than other imaging technologies, NETSPOT gives doctors a better picture of the disease and what they have to treat.

“Patients who are diagnosed with NETs early have a better chance of beating or managing the disease,” said Dr. Lavely.

NETSPOT is currently available at Northside Hospital imaging centers in Atlanta, Cumming, Decatur, Fayetteville and Lawrenceville.

Share

Piedmont Healthcare to Open 27 Retail Clinics

Saturday, August 26th, 2017

Retail clinics located in 27 Walgreens stores in metro Atlanta will become an extension of Piedmont Healthcare beginning this month. Called Piedmont QuickCare at Walgreens, the retail clinics offer consumers increased access to healthcare services for minor injuries and illnesses that are not life threatening.

QuickCare Ribbon Cutting

“Our goal in opening Piedmont QuickCare locations is to make it as easy as possible for people to get the care they need, when they need it,” said Kevin Brown, CEO of Piedmont Healthcare. “We’re proud to be able to expand into these areas and provide high-quality, patient-centered care close to home for our patients.”

The retail clinics will complement Piedmont Healthcare’s existing virtual care (Piedmont OnCall), primary care and urgent care options. With extended walk-in hours and convenient online scheduling, Piedmont QuickCare at Walgreens will make it easier for consumers to take charge of their health.

“At Piedmont, we’re always looking for opportunities to improve the patient experience by making it easy to access care where and when it is the most convenient for the patient,,” Brown said. “The team at Piedmont QuickCare will be able to treat anything from aches and pains to ongoing health conditions like high blood pressure and diabetes. Plus, patients will be able to pick up medications they need onsite.”

In February, Piedmont and Walgreen announced they would form a collaborative council to share best practices and experiences aimed at improving patient care, quality and satisfaction while reducing healthcare costs. The new clinic agreement builds on an existing relationship between the two organizations that dates back to 2009.

Share

Northside Hospital and Gwinnett Health System Reach Agreement on Combining Operations

Wednesday, August 30th, 2017

Northside Hospital and Gwinnett Health System (the parent of Gwinnett Medical Center) announced that they have submitted their proposed merger agreement to the State of Georgia Office of the Attorney General for review and approval. Depending on the review process, the five-hospital Northside-Gwinnett Health combined system could be operational in early 2018.

Northside Hospital and Gwinnett Health System previously announced that they had signed a letter of intent to begin discussions to combine their operations. Both systems have taken the necessary time  to conduct this process carefully and deliberately. The primary due diligence and planning process has concluded and the systems are moving forward with the proposed merger.  

Anchored by Northside Hospital in Sandy Springs and Gwinnett Medical Center in Lawrenceville, the new health system also will include hospitals in Canton, Cumming and Duluth, as well as cancer treatment centers, imaging centers, urgent care centers and other outpatient locations throughout the state. Altogether, the Northside-Gwinnett combined system will have 1,479 beds, nearly 21,000 employees and 3,500 physicians on staff.

Share

Secretary Price Appoints Brenda Fitzgerald, M.D., as CDC Director and ATSDR Administrator

Monday, July 24th, 2017

Dr. Brenda Fitzgerald

Health and Human Services Secretary Tom Price, M.D., named Brenda Fitzgerald, M.D., as the 17th Director of the Centers for Disease Control and Prevention (CDC) and Administrator of the Agency for Toxic Substances and Disease Registry (ATSDR).

“Today, I am extremely proud and excited to announce Dr. Brenda Fitzgerald as the new Director of the CDC,” said Secretary Price. “Having known Dr. Fitzgerald for many years, I know that she has a deep appreciation and understanding of medicine, public health, policy and leadership—all qualities that will prove vital as she leads the CDC in its work to protect America’s health 24/7. We look forward to working with Dr. Fitzgerald to achieve President Trump’s goal of strengthening public health surveillance and ensuring global health security at home and abroad. Congratulations to Dr. Fitzgerald and her family.”

Dr. Fitzgerald has been the commissioner of the Georgia Department of Public Health (DPH) and state health officer for the past six years. She replaces Dr. Anne Schuchat, who has been the acting CDC director and acting ATSDR administrator since January 20. Dr. Schuchat is returning to her role as CDC’s principal deputy director.

“Additionally, I’d like to extend my deep appreciation and thanks to Dr. Anne Schuchat for her exemplary service as acting director of the CDC,” said Secretary Price. “We thank Dr. Schuchat and her team for their dedication in our public health efforts to keep Americans safe and for their work to ensure a seamless transition. We look forward to continuing to work with Dr. Schuchat in her role as principal deputy director of CDC.”

Dr. Fitzgerald, a board-certified obstetrician-gynecologist, has practiced medicine for three decades. As Georgia DPH Commissioner, Dr. Fitzgerald oversaw various state public health programs and directed the state’s 18 public health districts and 159 county health departments. Prior to that, Dr. Fitzgerald held numerous leadership positions. She served on the board and as president of the Georgia OB-GYN Society and she worked as a health care policy advisor with House Speaker Newt Gingrich and Senator Paul Coverdell. She has served as a Senior Fellow and Chairman of the Board for the Georgia Public Policy Foundation.

Dr. Fitzgerald holds a Bachelor of Science degree in Microbiology from Georgia State University and a Doctor of Medicine degree from Emory University School of Medicine. She completed post-graduate training at the Emory-Grady Hospitals in Atlanta and held an assistant clinical professorship at Emory Medical Center. As a Major in the U.S. Air Force, Dr. Fitzgerald served at the Wurtsmith Air Force Strategic Air Command (SAC) Base in Michigan and at the Andrews Air Force Base in Washington, D.C.

Share

Rob Schreiner, M.D. Named as New President for WellStar Medical Group

Monday, July 24th, 2017

Rob Schreiner, M.D.

WellStar Health System announced the appointment of Rob Schreiner, M.D. as executive vice president and president of WellStar Medical Group (WMG). In his role, Dr. Schreiner will oversee the group’s continued growth and integration within the health system.

WellStar Medical Group, which began in 1994 with around 100 physicians, has grown to be one of the largest medical groups in the state, with 1,150 providers across 40-plus specialties at 250 locations.

“As a physician with extensive medical group leadership experience, Rob brings a unique perspective,” said Candice Saunders, president & CEO of WellStar Health System. “He has a track record of improving patient outcomes while lowering cost through a team-centered approach which will lead to better health outcomes for our patients and communities.”

Dr. Schreiner is a pulmonary and critical care physician with more than 20 years of executive-level experience in population healthcare and physician leadership development. Most recently, Dr. Schreiner served as executive medical director of the Studer Group, a healthcare consulting company which works with organizations on improving clinical outcomes and financial results. Other professional experience includes managing director of Population Health for the Huron Consulting Group and various positions with Kaiser Permanente Georgia, including chief operating officer, executive medical director, and chief of Medical-Hospitalist Services and Pulmonary Care Services.

“When I learned of this position, I thought what a great opportunity to make a contribution to physician leadership and advance the great care WellStar is known for in the community,” Schreiner said. “Our emphasis on team-based care, patient safety, and continuous improvement has enabled our success. I expect that emphasis and success to not only continue, but accelerate, into the next decade.”

A graduate of the University of Tennessee School of Medicine, Dr. Schreiner completed his residency in Internal Medicine at Vanderbilt University Medical Center and a Pulmonary and Critical Care fellowship at the University of Colorado Health Services Center.

Share

Grady Opens Marcus Stroke and Neuroscience Outpatient Center

Monday, July 24th, 2017

Grady Health System’s Marcus Stroke and Neuroscience Center is expanding its care with the opening of its new outpatient center. Unveiled during ceremonies in June, the center provides a multi-disciplinary approach to care for patients with advanced neurological conditions. The outpatient center is the first phase of an expansion that will allow the Marcus Stroke and Neuroscience Center to serve more patients and expand its research capabilities.

Marcus Neuroscience Outpatient Center Opening

“Grady’s reputation as a regional destination for the advanced treatment of stroke and other neurological issues has led to significant growth. This new outpatient center will provide access to a greater number of patients who will benefit from our cutting-edge care,” said Grady CEO John Haupert.

The expansion was made possible by a $10 million gift from The Marcus Foundation, which under the direction of its benefactors, Billi and Bernie Marcus, has invested more than $50 million in Grady since 2009. A significant portion of those funds went to the creation of the Marcus Stroke and Neuroscience Center.

“We believed we could make an incredible impact on the treatment of stroke and neurological conditions here at Grady, and we have.” said Bernie Marcus, who attended Monday’s event. “Hundreds if not thousands of patients have been saved not only by the cutting edge treatment offered here, but through research that has turned into life-saving solutions. What we have accomplished – and will continue to accomplish in the future – is something we can all be very proud of.”

The new outpatient center centralizes diagnosis and treatment functions, allowing for enhanced patient care coordination.

“It is impossible to overstate the impact The Marcus Foundation has had on Grady. This health system is thriving today in large part due to Billi and Bernie’s willingness to invest in our future and challenge us not only to deliver the best possible care, but set standards that will save lives for years to come,” said Pete Correll, chair of the Grady Health Foundation.

Share

Newnan Dermatology welcomes Dr. Samit Patrawala

Monday, July 24th, 2017

Dr. Patrawala

Newnan Dermatology announces the addition of board-certified dermatologist Dr. Samit Patrawala to its roster of physicians.

“We’re thrilled to bring Dr. Patrawala on board with Newnan Dermatology,” said Newnan Dermatology senior partner and president Dr. Mark Ling. “With his strong history of academic recognitions and community outreach, Dr. Patrawala certainly fits well with our practice model of professionalism and compassion.”

Dr. Patrawala, a native of Michigan, graduated summa cum laude from the University of South Alabama with a Bachelor of Science in biomedical science and received his medical degree from Vanderbilt University School of Medicine. He completed an internship at University of Chicago NorthShore before completing his dermatology residency at Emory University. He is currently finishing further training in dermatopathology at Emory University. Dr. Patrawala has authored multiple publications in scholarly journals and looks forward to continuing his academic interests in skin disease.

“Being personable and forming relationships with my patients are my strong suits,” said Dr. Patrawala. “I strongly believe in personalized care. I strive to learn my patients’ goals so we can come together to craft a treatment plan that achieves their desired outcomes.”

Dr. Patrawala joins Dr. Jill Buckthal, Dr. Mark Holzberg, Dr. Steven Marcet, and Dr. Mark Ling as part of the Newnan Dermatology team, which has two locations in Newnan and Peachtree City.

Share

Dr. Darrell Carmen receives Father of the Year award

Friday, June 9th, 2017

Darrell J. Carmen, MD

Dr. Darrell Carmen of Georgia Urology may be a noted physician, but first and foremost he’s a father. The Father’s Day Council, a philanthropic nonprofit, recognizes this. On June 29 at the College Football Hall of Fame in Downtown Atlanta, Dr. Carmen will be one of a handful of Georgia-based recipients honored at the Father’s Day Council’s Father of the Year Awards benefitting the American Diabetes Association.

This ceremony salutes men in Georgia who keep their families as the number one priority in their lives while simultaneously juggling challenging careers and community interaction. These annual awards, which take place in select cities across the country, attempt to heighten awareness of the importance of fatherhood.
“Often times we’re defined by the professions we choose,” said Dr. Carmen, “or the degrees and career accomplishments we attain along the way. At the end of the day, the gift of fatherhood is the greatest honor and privilege I’ll ever receive.”
In addition to receiving the Father of the Year Tribute Trophy, Dr. Carmen will be celebrated as a community leader and devoted dad in the form of a video presentation. He will be sharing the spotlight as part of a quartet of distinguished honorees, who also serve as forerunners in their respective communities. In addition to Dr. Carmen, the Father of the Year Awards honors Vince Dooley, former University of Georgia head football coach and director of athletics; David V. Martin, Ph.D, former executive director of the Georgia Council on Economic Education; and Thomas Carroll, head of division wealth management at SunTrust Bank.
Proceeds from event ticket sales help support the American Diabetes Association. This organization strives to prevent and cure diabetes, and improve the lives of all people affected by the disease. Together since 2000, the Father’s Day Council and the American Diabetes Association have raised more than $40 million for the American Diabetes Association.
“As a urologist, I frequently see ailments caused or complicated by diabetes,” Dr. Carmen said. “While my goal is to be the best father I can be, I also hope to leave the world a bit healthier than I found it. I’m happy to see this fundraiser attempting to do just that.”
Dr. Carmen, a married father of two, is a member of the American Urological Association, National Medical Association, American Association of Clinical Urologists, and American College of Surgeons. With specialized training in robotic surgery and InterStim therapy, Dr. Carmen has urologic expertise in prostate cancer, erectile dysfunction, penile implant surgery, urinary incontinence, and kidney stones.
Share

 

 
Resources F T L Subscription Advertising About Us Past Issues Contact